Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Moderate Reduction in LVEF Is Associated with an Increased Risk of Post-HSCT Symptomatic Cardiomyopathy

Kinjal Parikh, MD, Lekha Mikkilineni, MD, Fern Martin, MD, Dolores Grosso, R.N., CRNP, DNP, Benjamin Leiby, PhD, Onder Alpdogan, MD, Matthew Carabasi, MD, Margaret Kasner, MD, Thomas R. Klumpp, MD, Ubaldo Martinez Outschoorn, MD, Manish Sharma, MD, Mark Weiss, MD, John L. Wagner, MD, Neal Flomenberg, MD, Joanne Filicko-O'Hara, MD

Blood (2015) 126 (23): 2023.

https://doi.org/10.1182/blood.V126.23.2023.2023

Published: 2015

Journal Articles

Analysis of Early Mortality of Chronic Lymphocytic Leukemia (CLL) Patients Treated in US Practices in the Connect CLL® Registry

Charles M. Farber, MD, Anthony Mato, MD, Chadi Nabhan, MD, Thomas J. Kipps, MD, PhD, Christopher Flowers, MD, Neil E. Kay, MD, Nicole Lamanna, MD, David L. Grinblatt, MD, Mark Kozloff, MD, Mark Weiss, MD, Kristen Sullivan, E. Dawn Flick, RPh, MPH, ScD, Pavel Kiselev, PhD, Shriya Bhushan, PharmD, Arlene S. Swern, PhD, Jeff P. Sharman, MD

Blood (2015) 126 (23): 5270.

https://doi.org/10.1182/blood.V126.23.5270.5270

Published: 2015

Journal Articles

Detection of Acquired Uniparental Disomy (aUPD) with HLA Typing and Microarray Analysis after T Cell-Containing Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT)

Dolores Grosso, DNP, Beth Colombe, PhD, Zi-Xuan Wang, PhD, Matthew Carabasi, MD, Onder Alpdogan, MD, Joanne E. Filicko-O'Hara, MD, Margaret Kasner, MD, Thomas R. Klumpp, MD, Ubaldo Martinez-Outschoorn, MD, Manish Sharma, MD, John L. Wagner, MD, Mark Weiss, MD, Neal Flomenberg, MD

Blood (2015) 126 (23): 3165.

https://doi.org/10.1182/blood.V126.23.3165.3165

Published: 2015

Journal Articles

Creatinine > 1.5 Mg/Dl and MDS Diagnosis Predicts Poor Outcome Following HSCT

Fern Martin, MD, Lekha Mikkilineni, MD, Kinjal Parikh, MD, Dolores Grosso, DNP, Benjamin E Leiby, PhD, Onder Alpdogan, MD, Matthew Carabasi, MD, Margaret Kasner, MD, Thomas R. Klumpp, MD, Ubaldo Martinez-Outschoorn, MD, Manish Sharma, MD, Mark Weiss, MD, John L. Wagner, MD, Neal Flomenberg, MD, Joanne Filicko-O'Hara, MD

Blood (2015) 126 (23): 3220.

https://doi.org/10.1182/blood.V126.23.3220.3220

Published: 2015

Journal Articles

Smoking History and Pre-Transplant Pulmonary Function Predict Post-Transplant Respiratory Failure, Acute Renal Failure Requiring Dialysis and 100-Day Mortality in Allogeneic Bone Marrow Transplantation

Lekha Mikkilineni, MD, Kinjal Parikh, MD, Fern Martin, MD, Dolores Grosso, R.N., CRNP, DNP, Benjamin Leiby, PhD, Onder Alpdogan, MD, Matthew Carabasi, MD, Margaret Kasner, MD, Thomas R. Klumpp, MD, Ubaldo Martinez-Outschoorn, MD, Manish Sharma, MD, Mark Weiss, MD, John L. Wagner, MD, Neal Flomenberg, MD, Joanne E. Filicko-O'Hara, MD

Blood (2015) 126 (23): 4394.

https://doi.org/10.1182/blood.V126.23.4394.4394

Published: 2015

Journal Articles

Patterns of Care of Aged Chronic Lymphocytic Leukemia Patients in the United States: Systematic Analysis of 457 Patients in the Connect CLL Registry

Chadi Nabhan, MD FACP, Natalie Galanina, MD, Neil E. Kay, MD, Anthony R. Mato, MD, David L. Grinblatt, MD, Thomas J. Kipps, MD, Nicole Lamanna, MD, Mark Weiss, MD, Ian Flinn, Arlene S. Swern, PhD, Thomas Street, Sullivan Kristen, MBA, Christopher R. Flowers, MD

Blood (2014) 124 (21): 4672.

https://doi.org/10.1182/blood.V124.21.4672.4672

Published: 2014

Journal Articles

Demographics By Age Group (AG) and Line of Therapy (LOT) in Chronic Lymphocytic Leukemia (CLL) Patients (Pts) Treated in US Practices from the Connect ® CLL Registry

Jeff P. Sharman, MD, Anthony Mato, Neil E. Kay, MD, Thomas J. Kipps, MD, Nicole Lamanna, Mark Weiss, MD, Chadi Nabhan, Ian Flinn, David L. Grinblatt, Mark F. Kozloff, Charles M. Farber, Kirsten Sullivan, Thomas Street, Arlene S. Swern, PhD, Christopher R. Flowers, MD

Blood (2014) 124 (21): 3338.

https://doi.org/10.1182/blood.V124.21.3338.3338

Published: 2014

Journal Articles

Clinical Outcomes of 2-Step Approach to Haploidentical Hematopoietic Stem Cell Transplantation (HSCT): Effects of CD34 Stem Cell Dose in the Setting of a Consistent T-Cell Dose

Sameh Gaballa, MD, Neil D. Palmisiano, MD, Onder Alpdogan, MD, Matthew Carabasi, MD, Joanne Filicko-O'Hara, MD, Margaret Kasner, MD, Ubaldo Martinez, MD, John L. Wagner, MD, Mark Weiss, MD, Neal Flomenberg, MD, Dolores Grosso, DNP

Blood (2014) 124 (21): 1212.

https://doi.org/10.1182/blood.V124.21.1212.1212

Published: 2014

Journal Articles

CD3/8 T-Cell Responses to CMV Reactivation in Patients Undergoing Haploidentical Transplants: A Retrospective Analysis

Mahasweta Gooptu, MD, Benjamin Leiby, Onder Alpdogan, MD, Matthew Carabasi, MD, Joanne Filicko-O'Hara, MD, Margaret Kasner, MD, Thomas R. Klumpp, MD, Ubaldo Martinez, MD, Barbara Pro, MD, Manish Sharma, MD, John L. Wagner, MD, Mark Weiss, MD, Neal Flomenberg, MD, Dolores Grosso, DNP

Blood (2014) 124 (21): 1170.

https://doi.org/10.1182/blood.V124.21.1170.1170

Published: 2014

Journal Articles

A 2 Step Approach To Myeloablative Haploidentical Hematopoietic Stem Cell Transplantation (HSCT): Low Non-Relapse Related Mortality (NRM) and High Overall Survival (OS) Rates Confirmed In Second Generation Trial

Dolores Grosso, DNP, Onder Alpdogan, MD, Matthew Carabasi, MD, Joanne Filicko-O'Hara, MD, Margaret Kasner, MD, Ubaldo Martinez, MD, William O'Hara, PharmD, John L. Wagner, MD, Mark Weiss, MD, Neal Flomenberg, MD

Blood (2013) 122 (21): 3360.

https://doi.org/10.1182/blood.V122.21.3360.3360

Published: 2013

Journal Articles

The Addition Of Bortezomib (Velcade®) To The Combination Of Mitoxantrone and Etoposide For Relapsed Or Refractory Acute Leukemia Does Not Appear To Improve The Likelihood Of Response: Results Of a Phase II Trial

Neil D. Palmisiano, MD, Sameh Gaballa, MD, Bijoyesh Mookerjee, MD, John L. Wagner, MD, Margaret Kasner, MD, Matthew Carabasi, MD, Onder Alpdogan, MD, Ubaldo Martinez, MD, Mark Weiss, MD, Neal Flomenberg, MD, Joanne Filicko-O'Hara, MD

Blood (2013) 122 (21): 2689.

https://doi.org/10.1182/blood.V122.21.2689.2689

Published: 2013

Journal Articles

Aerobic Glycolysis Predicts Outcome in Early Chronic Lymphocytic Leukemia.

Jeffrey R Gardner, MBA, Sean Devlin, PhD, Kristina Knapp, Francesco Bauli, MS, Nicole Lamanna, MD, Mark G. Frattini, MD, PhD, Renier J Brentjens, MD, PhD, Peter G. Maslak, M.D., Joseph G. Jurcic, MD, Mark Weiss, MD, David A. Scheinberg, MD, PhD, Mark Heaney, MD, PhD

Blood (2012) 120 (21): 2482.

https://doi.org/10.1182/blood.V120.21.2482.2482

Published: 2012

Journal Articles

Sirolimus Plus MEC Chemotherapy Has Significant Activity in High Risk AML Patients Especially Those Who Exhibit in Vivo Inhibition of the mTOR Pathway

Blood (2012) 120 (21): 143.

https://doi.org/10.1182/blood.V120.21.143.143

Published: 2012

Journal Articles

High Dose Cytarabine and Mitoxantrone in Combination with Dasatinib As Active Induction Therapy in Adult Patients with Philadelphia Chromosome Positive (ph+) Acute Lymphoblastic Leukemia (ALL)

Nicole Lamanna, MD, Mark Weiss, MD, Ellin Berman, MD, Mark G. Frattini, MD, PhD, Mark Heaney, MD, PhD, Joseph G. Jurcic, MD, Todd L. Rosenblat, MD, Heather Landau, MD, Hanna Weissbrot, BA, Peter G. Maslak, M.D.

Blood (2012) 120 (21): 4293.

https://doi.org/10.1182/blood.V120.21.4293.4293

Published: 2012

Journal Articles

Variation in Health-Related Quality of Life by Line of Therapy of Patients with Chronic Lymphocytic Leukemia

Neil E. Kay, MD, Christopher R. Flowers, MD, Mark Weiss, MD, Nicole Lamanna, MD, Ian W. Flinn, MD, PhD, David Grinblatt, MD, Thomas J. Kipps, MD, PhD, Mark Kozloff, Susan Lerner, MS, Jeff Sharman, MD, Ren Yu, MA, Zeba M. Khan, PhD, Thomas K. Street, RPh, Arlene S. Swern, PhD, Kristen A. Sullivan, MBA, Chris L Pashos, PhD

Blood (2012) 120 (21): 3926.

https://doi.org/10.1182/blood.V120.21.3926.3926

Published: 2012

Journal Articles

Variation in Health-Related Quality of Life by Age Among Patients with Chronic Lymphocytic Leukemia

Chris L. Pashos, PhD, Christopher R Flowers, MD, Mark Weiss, MD, Nicole Lamanna, MD, Charles M Farber, MD, PhD, Thomas J. Kipps, M.D., Ph.D, Susan Lerner, MS, BA, Neil Kay, MD, Jeff Porte Sharman, MD, David L. Grinblatt, MD, Ian W. Flinn, MD, PhD, Mark Kozloff, MD, Arlene S Swern, PhD, Zeba M. Kahn, Ph.D, Thomas K. Street, RPh, Kristen A Sullivan, MBA, Gale Harding, MA, Michael J Keating, MD

Blood (2011) 118 (21): 2085.

https://doi.org/10.1182/blood.V118.21.2085.2085

Published: 2011

Journal Articles

Patterns of Care for Patients with Chronic Lymphocytic Leukemia (CLL): The Connect ® CLL Disease Registry

Jeff Sharman, MD, Christopher R Flowers, MD, Mark Weiss, MD, David Grinblatt, MD, Charles Farber, MD, PhD, Neil Kay, MD, Thomas Kipps, MD, Nicole Lamanna, MD, Chris Pashos, PhD, Ian W Flinn, MD, Mark Kozloff, MD, Susan Lerner, MS, Arlene S Swern, PhD, Kristen A Sullivan, MBA, Thomas K. Street, RPh, Michael Keating, MBBS

Blood (2011) 118 (21): 2864.

https://doi.org/10.1182/blood.V118.21.2864.2864

Published: 2011

Journal Articles

Elevated Mitochondrial Membrane Potential in CLL Cells Is Associated with a more aggressive Natural History

Jeffrey R Gardner, MBA, Kristina Knapp, Mark G. Frattini, MD, PhD, Nicole Lamanna, MD, Renier Brentjens, MD, PhD, Joseph G Jurcic, MD, Peter G. Maslak, M.D., Ellin Berman, MD, Mark Weiss, MD, David A. Scheinberg, MD, PhD, Mark Heaney, MD, PhD

Blood (2011) 118 (21): 1765.

https://doi.org/10.1182/blood.V118.21.1765.1765

Published: 2011

Journal Articles

Variation in Health-Related Quality of Life by ECOG Performance Status and Fatigue Among Patients with Chronic Lymphocytic Leukemia

Chris L. Pashos, PhD, Christopher R Flowers, MD, Mark Weiss, MD, Nicole Lamanna, MD, Charles M Farber, MD, PhD, Thomas J. Kipps, M.D., Ph.D, Susan Lerner, MS, BA, Neil Kay, MD, Jeff Porte Sharman, MD, David L. Grinblatt, MD, Ian W. Flinn, MD, PhD, Mark Kozloff, MD, Arlene S Swern, PhD, Zeba M. Kahn, Ph.D, Thomas K. Street, RPh, Gale Harding, MA, Kristen A Sullivan, MBA, Michael J Keating, MD

Blood (2011) 118 (21): 4591.

https://doi.org/10.1182/blood.V118.21.4591.4591

Published: 2011

Journal Articles

Phase II Study of Bortezomib, Mitoxantrone and Etoposide In Relapsed/ Refractory Acute Leukemias

Joanne Filicko-O'Hara, MD, Bijoyesh Mookerjee, MBBS, Onder Alpdogan, MD, Emmanuel C. Besa, MD, Matthew Carabasi, MD, Elena Gitelson, MD, Margaret Kasner, MD, John L. Wagner, MD, Mark Weiss, MD, Neal Flomenberg, MD

Blood (2010) 116 (21): 2192.

https://doi.org/10.1182/blood.V116.21.2192.2192

Published: 2010

NARROW

Moderate Reduction in LVEF Is Associated with an Increased Risk of Post-HSCT Symptomatic Cardiomyopathy

Analysis of Early Mortality of Chronic Lymphocytic Leukemia (CLL) Patients Treated in US Practices in the Connect CLL® Registry

Detection of Acquired Uniparental Disomy (aUPD) with HLA Typing and Microarray Analysis after T Cell-Containing Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT)

Creatinine > 1.5 Mg/Dl and MDS Diagnosis Predicts Poor Outcome Following HSCT

Smoking History and Pre-Transplant Pulmonary Function Predict Post-Transplant Respiratory Failure, Acute Renal Failure Requiring Dialysis and 100-Day Mortality in Allogeneic Bone Marrow Transplantation

Patterns of Care of Aged Chronic Lymphocytic Leukemia Patients in the United States: Systematic Analysis of 457 Patients in the Connect CLL Registry

Demographics By Age Group (AG) and Line of Therapy (LOT) in Chronic Lymphocytic Leukemia (CLL) Patients (Pts) Treated in US Practices from the Connect ® CLL Registry

Clinical Outcomes of 2-Step Approach to Haploidentical Hematopoietic Stem Cell Transplantation (HSCT): Effects of CD34 Stem Cell Dose in the Setting of a Consistent T-Cell Dose

CD3/8 T-Cell Responses to CMV Reactivation in Patients Undergoing Haploidentical Transplants: A Retrospective Analysis

A 2 Step Approach To Myeloablative Haploidentical Hematopoietic Stem Cell Transplantation (HSCT): Low Non-Relapse Related Mortality (NRM) and High Overall Survival (OS) Rates Confirmed In Second Generation Trial

The Addition Of Bortezomib (Velcade®) To The Combination Of Mitoxantrone and Etoposide For Relapsed Or Refractory Acute Leukemia Does Not Appear To Improve The Likelihood Of Response: Results Of a Phase II Trial

Aerobic Glycolysis Predicts Outcome in Early Chronic Lymphocytic Leukemia.

Sirolimus Plus MEC Chemotherapy Has Significant Activity in High Risk AML Patients Especially Those Who Exhibit in Vivo Inhibition of the mTOR Pathway

High Dose Cytarabine and Mitoxantrone in Combination with Dasatinib As Active Induction Therapy in Adult Patients with Philadelphia Chromosome Positive (ph+) Acute Lymphoblastic Leukemia (ALL)

Variation in Health-Related Quality of Life by Line of Therapy of Patients with Chronic Lymphocytic Leukemia

Variation in Health-Related Quality of Life by Age Among Patients with Chronic Lymphocytic Leukemia

Patterns of Care for Patients with Chronic Lymphocytic Leukemia (CLL): The Connect ® CLL Disease Registry

Elevated Mitochondrial Membrane Potential in CLL Cells Is Associated with a more aggressive Natural History

Variation in Health-Related Quality of Life by ECOG Performance Status and Fatigue Among Patients with Chronic Lymphocytic Leukemia

Phase II Study of Bortezomib, Mitoxantrone and Etoposide In Relapsed/ Refractory Acute Leukemias

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only